Department of Medical Oncology
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
肿瘤内科 · Medical Oncology
Established in May 2001, this department provides comprehensive diagnosis, treatment, and follow-up for various solid tumors and lymphomas. Services include chemotherapy, molecular targeted therapy, cell immunotherapy (such as DC-CIK), hyperthermia, and pain management. The team emphasizes personalized treatment plans based on biomarker testing (including KRAS, dMMR, HER-2, and EGFR) and offers multidisciplinary team (MDT) consultations with surgery, radiotherapy, and pathology specialists. The department manages approximately 8,200 patient cases annually across 78 beds. It participates in over 40 clinical trials, including international multi-center studies, and treats rare tumors such as desmoplastic small round cell tumors and neuroendocrine tumors.
What the department treats
- Chemotherapy (adjuvant, neoadjuvant, and palliative)
- Molecular targeted therapy and biomarker-guided treatment
- Cell immunotherapy (DC-CIK) and biological therapy
- Multidisciplinary team (MDT) comprehensive diagnosis and treatment
- Treatment of rare tumors and drug-resistant cases
- Pain management and palliative care
Key facts
- The department was established in May 2001.
- There are 78 open beds and approximately 8,200 patient cases treated annually.
- The department participates in more than 40 clinical trials.
As described by the hospital.
Team
27 doctors listed.
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion